Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Georg Feldmann

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience From a Cohort of 110 Consecutive Cases

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2020English

Related publications

[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Dosimetry of Lu-177 PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pre-Therapeutic Imaging and “Whole Body” Tumor Dosimetry With Treatment Outcomes

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Targeted Α-Therapy of Metastatic Castration-Resistant Prostate Cancer With225Ac-Psma-617: Dosimetry Estimate and Empiric Dose Finding

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Predictive Factors of Response and Overall Survival in Patients With Castration-Resistant Metastatic Prostate Cancer Undergoing177Lu-Psma Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer

Urologic Clinics of North America
Urology
2012English

Molecular Drivers of Metastatic Castrate-Resistant Prostate Cancer: New Roads to Resistance

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Results From Extended Lymphadenectomies With [111In]PSMA-617 for Intraoperative Detection of PSMA-PET/CT-positive Nodal Metastatic Prostate Cancer

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy